159 related articles for article (PubMed ID: 31222761)
21. Overexpression of NaV 1.6 channels is associated with the invasion capacity of human cervical cancer.
Hernandez-Plata E; Ortiz CS; Marquina-Castillo B; Medina-Martinez I; Alfaro A; Berumen J; Rivera M; Gomora JC
Int J Cancer; 2012 May; 130(9):2013-23. PubMed ID: 21630263
[TBL] [Abstract][Full Text] [Related]
22. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
[TBL] [Abstract][Full Text] [Related]
23. Tetracaine downregulates matrix metalloproteinase activity and inhibits invasiveness of strongly metastatic MDA-MB-231 human breast cancer cells.
Keleş D; Sipahi M; İnanç-Sürer Ş; Djamgoz MB; Oktay G
Chem Biol Interact; 2023 Nov; 385():110730. PubMed ID: 37806380
[TBL] [Abstract][Full Text] [Related]
24. Caffeic acid phenethyl ester: Inhibition of metastatic cell behaviours via voltage-gated sodium channel in human breast cancer in vitro.
Fraser SP; Hemsley F; Djamgoz MBA
Int J Biochem Cell Biol; 2016 Feb; 71():111-118. PubMed ID: 26724521
[TBL] [Abstract][Full Text] [Related]
25. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
[TBL] [Abstract][Full Text] [Related]
26. Docosahexaenoic acid (omega-3) blocks voltage-gated sodium channel activity and migration of MDA-MB-231 human breast cancer cells.
Isbilen B; Fraser SP; Djamgoz MB
Int J Biochem Cell Biol; 2006; 38(12):2173-82. PubMed ID: 16931105
[TBL] [Abstract][Full Text] [Related]
27. Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells.
Gillet L; Roger S; Besson P; Lecaille F; Gore J; Bougnoux P; Lalmanach G; Le Guennec JY
J Biol Chem; 2009 Mar; 284(13):8680-91. PubMed ID: 19176528
[TBL] [Abstract][Full Text] [Related]
28. Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.
He Q; Jing H; Liaw L; Gower L; Vary C; Hua S; Yang X
Sci Rep; 2016 Mar; 6():23216. PubMed ID: 26976794
[TBL] [Abstract][Full Text] [Related]
29. Estrogen and non-genomic upregulation of voltage-gated Na(+) channel activity in MDA-MB-231 human breast cancer cells: role in adhesion.
Fraser SP; Ozerlat-Gunduz I; Onkal R; Diss JK; Latchman DS; Djamgoz MB
J Cell Physiol; 2010 Aug; 224(2):527-39. PubMed ID: 20432453
[TBL] [Abstract][Full Text] [Related]
30. Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels.
Djamgoz MBA
Br J Cancer; 2024 May; 130(9):1415-1419. PubMed ID: 38424164
[TBL] [Abstract][Full Text] [Related]
31. Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels.
Gumushan Aktas H; Akgun T
Biomed Pharmacother; 2018 Oct; 106():770-775. PubMed ID: 29990870
[TBL] [Abstract][Full Text] [Related]
32. Functional expression of voltage-gated sodium channels Nav1.5 in human breast cancer cell line MDA-MB-231.
Gao R; Wang J; Shen Y; Lei M; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):64-7. PubMed ID: 19224165
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade.
Choy C; Raytis JL; Smith DD; Duenas M; Neman J; Jandial R; Lew MW
Oncol Rep; 2016 Jun; 35(6):3135-42. PubMed ID: 27035124
[TBL] [Abstract][Full Text] [Related]
34. Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines.
Plummer HK; Yu Q; Cakir Y; Schuller HM
BMC Cancer; 2004 Dec; 4():93. PubMed ID: 15603589
[TBL] [Abstract][Full Text] [Related]
35. Antiproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol analogs against breast cancer cell lines.
Sinka I; Kiss A; Mernyák E; Wölfling J; Schneider G; Ocsovszki I; Kuo CY; Wang HC; Zupkó I
Eur J Pharm Sci; 2018 Oct; 123():362-370. PubMed ID: 30010030
[TBL] [Abstract][Full Text] [Related]
36. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
37. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine.
Elajnaf T; Baptista-Hon DT; Hales TG
Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221
[TBL] [Abstract][Full Text] [Related]
38. Nav1.5 regulates breast tumor growth and metastatic dissemination in vivo.
Nelson M; Yang M; Millican-Slater R; Brackenbury WJ
Oncotarget; 2015 Oct; 6(32):32914-29. PubMed ID: 26452220
[TBL] [Abstract][Full Text] [Related]
39. Neonatal Nav1.5 protein expression in normal adult human tissues and breast cancer.
Yamaci RF; Fraser SP; Battaloglu E; Kaya H; Erguler K; Foster CS; Djamgoz MBA
Pathol Res Pract; 2017 Aug; 213(8):900-907. PubMed ID: 28698102
[TBL] [Abstract][Full Text] [Related]
40. Sigma-1 receptors modulate neonatal Na
Aydar E; Stratton D; Fraser SP; Djamgoz MB; Palmer C
Eur Biophys J; 2016 Oct; 45(7):671-683. PubMed ID: 27160185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
